Zhang Lingfu, Hou Chunsheng, Xu Zhi, Wang Lixin, Ling Xiaofeng, Xiu Dianrong
Department of General Surgery, Peking University Third Hospital, Beijing 100191, China.
Chin J Cancer Res. 2018 Feb;30(1):84-92. doi: 10.21147/j.issn.1000-9604.2018.01.09.
Although laparoscopic treatment of gallbladder cancer (GBC) has been explored in the last decade, long-term results are still rare. This study evaluates long-term results of intended laparoscopic treatment for suspected GBC confined to the gallbladder wall, based on our experience over 10 years.
Between August 2006 and December 2015, 164 patients with suspected GBC confined to the wall were enrolled in the protocol for laparoscopic surgery. The process for GBC treatment was analyzed to evaluate the feasibility of computed tomography (CT) and/or magnetic resonance imaging (MRI) combined with frozen-section examination in identifying GBC confined to the wall. Of 159 patients who underwent the intended laparoscopic radical treatment, 47 with pathologically proven GBC were investigated to determine the safety and oncologic outcomes of a laparoscopic approach to GBC.
Among the 164 patients, 5 patients avoided further radical surgery because of unresectable disease and 12 were converted to open surgery; in the remaining 147 patients, totally laparoscopic treatment was successfully accomplished. Extended cholecystectomy was performed in 37 patients and simple cholecystectomy in 10. The T stages based on final pathology were Tis (n=6), T1a (n=2), T1b (n=9), T2 (n=26), and T3 (n=4). Recurrence was detected in 11 patients over a median follow-up of 51 months. The disease-specific 5-year survival rate of these 47 patients was 68.8%, and rose to 85% for patients with a normal cancer antigen 19-9 (CA19-9) level.
The favorable long-term outcomes demonstrate the feasibility of combined CT/MRI and frozen-section examination in the selection of patients with GBC confined to the gallbladder wall, confirm the oncologic safety of laparoscopic treatment in selected GBC patients, and favor measurement of preoperative CA19-9 in the selection of GBCs suitable for laparoscopic treatment.
尽管在过去十年中已对腹腔镜治疗胆囊癌(GBC)进行了探索,但长期结果仍然少见。本研究基于我们十余年的经验,评估对局限于胆囊壁的疑似GBC进行腹腔镜治疗的长期结果。
2006年8月至2015年12月期间,164例局限于胆囊壁的疑似GBC患者被纳入腹腔镜手术方案。分析GBC治疗过程,以评估计算机断层扫描(CT)和/或磁共振成像(MRI)联合冰冻切片检查在识别局限于胆囊壁的GBC方面的可行性。在159例行预期腹腔镜根治性治疗的患者中,对47例经病理证实为GBC的患者进行调查,以确定腹腔镜治疗GBC的安全性和肿瘤学结局。
164例患者中,5例因疾病无法切除而避免了进一步的根治性手术,12例转为开放手术;在其余147例患者中,成功完成了完全腹腔镜治疗。37例行扩大胆囊切除术,10例行单纯胆囊切除术。根据最终病理结果,T分期为Tis(n = 6)、T1a(n = 2)、T1b(n = 9)、T2(n = 26)和T3(n = 4)。在中位随访51个月期间,11例患者出现复发。这47例患者的疾病特异性5年生存率为68.8%,癌胚抗原19-9(CA19-)水平正常的患者升至85%。
良好的长期结果表明,CT/MRI联合冰冻切片检查在选择局限于胆囊壁的GBC患者方面具有可行性,证实了腹腔镜治疗在选定GBC患者中的肿瘤学安全性,并支持在选择适合腹腔镜治疗的GBC时测量术前CA19-9。